# CBD Dominant Cannabis Anxiety Relief: Study Insights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-dominant-cannabis-anxiety-relief-study/ > **Published:** 2026-04-25T13:30:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-27T22:59:51-04:00 > **Clinical Summary:** Explore the CBD dominant cannabis anxiety relief study showing anxiolytic benefits and reduced anxiety over 30 days with specific cannabis products. --- #### Clinical Takeaway Clinical Takeaway: Cannabis flower products showed greater daily anxiety reduction compared to edibles in this 30-day study of adults seeking [anxiety relief](https://cedclinic.com/cannabis-based-medicine-ptsd-anxiety-relief/), though effects varied by cannabinoid composition. THC alone increased anxiety risk while CBD-containing products demonstrated anxiolytic benefit, suggesting product selection and form matter significantly for therapeutic outcomes in [anxiety management](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/). ### #9 Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products. **Citation:** Rosa Luiza et al. *Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.* International journal of environmental research and public health. 2026. PMID: 41752306. **Study type:** Journal Article, Randomized Controlled Trial  |  **Topic area:** Cannabidiol  |  **CED Score:** 11 Design: 5 Journal: 0 N: 2 Recency: 3 Pop: 2 Human: 1 Risk: -2 **Quality Gate Alerts:** - Preclinical only **Abstract:** Research shows that delta-9-tetrahydrocannabinol (THC) is linked to increased anxiety, while cannabidiol (CBD) may have anxiolytic effects. Cannabis use is often driven by coping with anxiety, though its daily impact on anxiety remains unclear. This study examined daily associations between cannabis use and anxiety across 30 days in adults who wanted to use cannabis for anxiety relief. Participants (N = 345) used flower or edible products ad libitum and were randomly assigned to groups by product type (CBD, THC, or THC + CBD). Each day, participants reported cannabis use in the past 24 h and rated their anxiety. Linear mixed-effects models tested whether anxiety changed over time, differed by cannabinoid group, and varied with use. Anxiety significantly decreased over the study period in both flower and edibles groups. In the flower group, THC + CBD and [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) had greater decreases in anxiety (39.5% and 34.8%, respectively) compared to THC products (7.8%). In the edibles group, when participants used CBD products, this was associated with a 24.9% reduction in anxiety over the 30 days. Findings underscore the importance of distinguishing cannabis effects by product type and cannabinoid composition and suggest that CBD-dominant edibles were associated with less anxiety over time in this naturalistic study.  |   |  [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.](https://cedclinic.com/cannabis-flower-anxiety-relief-study/) Explore how different cannabis product types impact anxiety relief daily and over time in adults seeking therapeutic benefits. [Read More](https://cedclinic.com/cannabis-flower-anxiety-relief-study/) [Endocannabinoid System Anxiety: Cannabis Flower vs Edibles](https://cedclinic.com/therapeutically-motivated-cannabis-use-anxiety/) Compare the effects of cannabis flower and edibles on anxiety through [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) focused on the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/). [Explore Insights](https://cedclinic.com/therapeutically-motivated-cannabis-use-anxiety/) [Therapeutically Motivated Cannabis Use for Anxiety: Study Insights](https://cedclinic.com/therapeutically-motivated-cannabis-use-anxiety-study/) Detailed study insights into cannabis use for anxiety relief, highlighting cannabinoid composition and product form effects. [Learn More](https://cedclinic.com/therapeutically-motivated-cannabis-use-anxiety-study/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=CBD%20Dominant%20Cannabis%20Anxiety%20Relief%3A%20Study%20Insights&url=https%3A%2F%2Fcedclinic.com%2Fcbd-dominant-cannabis-anxiety-relief-study%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcbd-dominant-cannabis-anxiety-relief-study%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=CBD%20Dominant%20Cannabis%20Anxiety%20Relief%3A%20Study%20Insights%20https%3A%2F%2Fcedclinic.com%2Fcbd-dominant-cannabis-anxiety-relief-study%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).